INSIGHTS ON PHARMACEUTICAL INSPECTION

• ADC Drug Products: Solutions To Manage Risks And Enhance Stability

  Discover how an integrated ADC strategy addresses containment, analytics, fill-finish, and inspection challenges to improve product protection, process reliability, and delivery performance.

• Autoinjector Testing: Addressing Sensitivity And Headspace Challenges

  Micron‑level defects can jeopardize autoinjector sterility. Learn how vacuum decay offers a deterministic, repeatable way to verify container integrity and strengthen quality assurance.

• A Closer Look At Multi-Lane Checkweighing In Pharma

  Learn how multi-lane checkweighing boosts operational efficiency, ensures accurate dosing, and simplifies changeovers, making it ideal for applications like dual-chamber sachets and nutraceutical products.

• Part II: Defining The Dye Ingress Operating Window

  Learn about the viscosity-driven limits of dye ingress testing, translating qualitative constraints into a quantitative feasibility boundary shaped by defect size, pressure behavior, and plunger mechanics.

• Supporting GLP-1 And Peptides With Integrated Solutions

  9/30/2025

  Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

• Glove Integrity Testing: Changes In EU GMP Annex 1

  6/25/2026

  EU GMP Annex 1 now defines clear expectations for glove integrity testing. Examine how reliability, efficiency, and equipment usability are becoming essential factors for maintaining compliance.

• How Software-Enabled Manual Visual Inspection Can Boost Your ROI

  7/14/2025

  Unlock hidden cost savings in pharma manufacturing. Learn how software-enabled manual visual inspection enhances efficiency, data integrity, and regulatory readiness without full automation's capital expense.

• Physical Contamination Detection

  3/23/2026

  Learn how physical contaminants enter production lines and how detection systems like metal detection and X-ray inspection help prevent defects and recalls to strengthen quality control.

• Lessons From FDA 483s And Warning Letters: Cleanroom Compliance

  12/8/2025

  Learn critical lessons from FDA 483 observations and Warning Letters to proactively address common GMP cleanroom compliance failures and build an inspection-ready facility.